首页 >
法规速递
-
Document: Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2026/2027-2026/5/26
2026-05-27查看详情 > -
Page: New Zealand-2026/7/8
2026-07-09查看详情 > -
Document: Presentation - Global collaboration in cardiovascular medicine development (M. Inoue)-2026/8/13
2026-08-14查看详情 > -
关于公开征求ICH《M11：临床电子结构化协调方案（CeSHarP）》指导原则草案意见的通知-2023/01/06
2023-01-06查看详情 > -
国家药监局药审中心关于发布《人乳头瘤病毒疫苗临床试验技术指导原则（试行）》的通告（2023年第40号）-2023/7/11
2023-07-13查看详情 > -
国家药监局药审中心关于发布《化学药改良型新药临床药理学研究技术指导原则（试行）》的通告（2024年第10号）-2024/2/4
2024-02-05查看详情 > -
Page: List of medicines under additional monitoring-2025/1/29
2025-02-05查看详情 > -
Document: Minutes - PDCO minutes of the 12-15 November 2024 meeting-2025/3/5
2025-03-06查看详情 > -
国家药监局关于发布《化妆品安全风险监测与评价管理办法》的公告（2025年第37号）-2025/4/9
2025-04-11查看详情 > -
Document: Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products-2025/5
2025-05-20查看详情 >
